Immunovia AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.11.18	Immunovia Interim Report January-September 2018 (PR Newswire)
05.11.18	Invitation to Presentation of Immunovia´s Interim Report January-September 2018 on November 7, 2018 (PR Newswire)
05.11.18	Invitation to Presentation of Immunovia´s Interim Report January-September 2018 on November 7, 2018 (PR Newswire)
26.10.18	Immunovia AB (Publ) Nomination Committee Appointed for AGM 2019 (PR Newswire)
26.10.18	Immunovia AB (Publ) Nomination Committee Appointed for AGM 2019 (PR Newswire)
08.10.18	Immunovia Announces Strategic Focus Centered on IMMray™ Blood-based Biomarker Signatures for Rheumatoid Arthritis Within Autoimmunity (PR Newswire)
08.10.18	Immunovia Announces Strategic Focus Centered on IMMray™ Blood-based Biomarker Signatures for Rheumatoid Arthritis Within Autoimmunity (PR Newswire)
04.10.18	Immunovia PanFAM-1 Clinical Trial now Available on ClinicalTrials.gov, the Largest Clinical Trials Database in the World (PR Newswire)
04.10.18	Immunovia PanFAM-1 Clinical Trial now Available on ClinicalTrials.gov, the Largest Clinical Trials Database in the World (PR Newswire)
28.09.18	Invitation to Conference Call Regarding Immunovia's Autoimmune Diseases Strategy on October 8, 2018 (PR Newswire)
28.09.18	Invitation to Conference Call Regarding Immunovia's Autoimmune Diseases Strategy on October 8, 2018 (PR Newswire)
24.08.18	Immunovia Interim Report, January-June 2018 (PR Newswire)
24.08.18	Immunovia Interim Report, January-June 2018 (PR Newswire)
23.08.18	Invitation to presentation of Immunovia's Interim Report January-June 2018 and Comments to the Previously Published Autoimmunity Study Results (PR Newswire)
23.08.18	Invitation to presentation of Immunovia's Interim Report January-June 2018 and Comments to the Previously Published Autoimmunity Study Results (PR Newswire)
22.08.18	Breakthrough in Autoimmune Testing - IMMrayTM Based Novel Biomarker Signature Identifies Patients With Anti-CCP Negative Rheumatoid Arthritis (PR Newswire)
15.08.18	Journal of Clinical Oncology Publishes That IMMray™ PanCan-d Serum Biomarker Test Detects Early Pancreatic Cancer With 96% Accuracy (PR Newswire)
03.08.18	Karolinska Institutet Participates in Immunovia's PanFAM-1 Prospective Clinical Study for Early Detection of Pancreatic Cancer Using Blood-based Test (PR Newswire)
03.08.18	Karolinska Institutet Participates in Immunovia's PanFAM-1 Prospective Clinical Study for Early Detection of Pancreatic Cancer Using Blood-based Test (PR Newswire)
08.06.18	Immunovia has Completed a Directed Share Issue of Approximately SEK 324 Million (PR Newswire)
22.05.18	Linköping University Hospital Second Swedish Site in Largest Ever Prospective Multicenter Clinical Study for Early Detection of Pancreatic Cancer (PR Newswire)
22.05.18	Linköping University Hospital Second Swedish Site in Largest Ever Prospective Multicenter Clinical Study for Early Detection of Pancreatic Cancer (PR Newswire)
12.03.18	Immunovia Announces Financial Targets (PR Newswire)
12.03.18	Immunovia Announces Financial Targets (PR Newswire)
09.05.16	Immunovia AB: Immunovia Joins More Than 40 Global Pancreatic Cancer Organizations at Inagural Meeting (Businesswire)
29.02.16	Immunovia Starts Collaboration with Multinational Life Science Company on New Systemic Lupus Erythematosus (SLE) Diagnostics Test (Businesswire)
10.02.16	Immunovia AB: Immunovia and Lund University start clinical validation studies of Systemic Lupus Erythematosus (SLE) biomarker signatures (Businesswire)
19.01.16	Immunovia AB: Immunovia and the University of Liverpool enter into a collaboration in a prospective clinical study (Businesswire)
18.12.15	Immunovia AB: White Paper Outlines Predicted Impact of New Biomarker Diagnostic Technology on Pancreatic Cancer Survival Rates (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Immunovia AB

Aktien Top/Flop

Meistgelesene Nachrichten